Publisher: John Wiley & Sons Inc
E-ISSN: 2050-0904|3|6|453-460
ISSN: 2050-0904
Source: Clinical Case Reports, Vol.3, Iss.6, 2015-06, pp. : 453-460
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Alemtuzumab in the Treatment of Chronic Lymphocytic Leukemia
BioDrugs, Vol. 19, Iss. 1, 2005-01 ,pp. :
By Kyriakides T.C. Babiker A. Singer J. Cameron W. Schechter M.T. Holodniy M. Brown S.T. Youle M. Gazzard B. on behalf of the OPTIMA Study Team see Appendix
Controlled Clinical Trials, Vol. 24, Iss. 4, 2003-08 ,pp. :